Ferulic AcidvsResveratrol

Ferulic acid is a hydroxycinnamic acid that scavenges free radicals (superoxide, hydroxyl, peroxyl) through its phenolic ring structure and conjugated double-bond system. When combined with vitamins C and E, it creates a synergistic antioxidant network: ferulic acid stabilizes L-ascorbic acid by preventing oxidation to dehydroascorbic acid, while the three compounds regenerate each other via redox cycling after neutralizing free radicals—extending the antioxidant capacity of the formulation. Ferulic acid absorbs UV light in the 290–330 nm range, providing direct photoprotection and reducing UV-induced DNA damage. It inhibits matrix metalloproteinase-1 (MMP-1, interstitial collagenase) expression, preventing UV-triggered collagen degradation. It also downregulates AP-1 and NF-κB signaling, reducing inflammatory mediators and UV-induced erythema. The landmark Pinnell formulation (15% L-AA + 1% alpha-tocopherol + 0.5% ferulic acid at pH 3.0–3.5) demonstrates these synergistic effects clinically.

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.